Sfoglia per Autore AGHEMO, Alessio Michele Goffredo
OSMOREGULATION OF VASOPRESSIN DURING ACUTE LOWERING OF ARTERIAL-PRESSURE BY CLONIDINE IN MODERATE HYPERTENSION
1989-01-01 Delbo, A; Marabini, M; Aghemo, A; Zanchetti, A
REGULATION OF VASOPRESSIN SECRETION AFTER ADMINISTRATION OF SODIUM-NITROPRUSSIDE IN HYPERTENSIVES
1991-01-01 Delbo, A; Marabini, M; Aghemo, A; Maffi, M; Suraci, S; Zanchetti, A
COINCIDENCE OF CALCITONIN-GENE-RELATED PEPTIDE IMMUNOREACTIVITY AND TERMINAL FIELDS OF EFFERENTS FROM THE CARDIOVASCULAR PORTION OF THE FASTIGIAL NUCLEUS - PRELIMINARY-REPORT
1993-01-01 Aghemo, A; Morara, S; Delbo, A; Rosina, A
The prevalence, clinical features and response to antiviral therapy of patients with chronic hepatitis C who are seropositive for liver-kidney microsome type 1 antibodies
2005-01-01 Monti, V; Aghemo, A; Rumi, Mg; Donato, Mf; Del Ninno, E; Colombo, M
US features of liver surface nodularity as a predictor of severe fibrosis in chronic hepatitis C
2005-01-01 Vigano, M; Visentin, S; Aghemo, A; Rumi, Mg; Ronchi, G
Impaired response to interferon-alpha 2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infection
2006-01-01 Aghemo, A; Rumi, Mg; Soffredini, R; D'Ambrosio, R; Ronchi, G; Del Ninno, E; Gallus, S; Colombo, M
The clinical impact of a 24-week treatment course of peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia
2006-01-01 Rumi, Mg; D'Ambrosio, R; Aghemo, A
The role of hepatic venous pressure gradient in hepatitis C virus compensated cirrhosis
2007-01-01 Vigano, M; Aghemo, A; Iavarone, M
Therapy expectations and physical comorbidity affect quality of life in chronic hepatitis C virus infection
2007-01-01 Taliani, G; Rucci, P; Biliotti, E; Cirrincione, L; Aghemo, A; Alberti, A; Almasio, Pl; Bartolozzi, D; Caporaso, N; Coppola, R; Chiaramonte, M; Floreani, A; Gaeta, Gb; Persico, M; Secchi, G; Versace, I; Zacharia, S; Mele, A
Lack of rapid virological response. predicts interferon-alpha 2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre study
2007-01-01 Rumi, Mg; Aghemo, A; D'Ambrosio, R; Ronchi, G; Del Ninno, E; Gallus, S; Colombo, M
Low risk of hepatitis B reactivation in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin
2008-01-01 Iavarone, M.; Aghemo, A.; Viganò, M.; Rumi, M. G.; Agnelli, F.; Lampertico, P.; Donato, M. F.; Colombo, M.
Recovery after L-DOPA treatment in peg-interferon and ribavirin induced parkinsonism
2008-01-01 Bersano, A.; Aghemo, A.; Rumi, M.; Ballabio, E.; Candelise, L.; Colombo, M.
Optimizing treatment with pegylated interferon-ribavirin of genotype 3 chronic hepatitis C : more questions than answers
2008-01-01 Aghemo, A.; D’Ambrosio, R.; Rumi, M. G.; Colombo, M.
Lack of Correlation Between Serum Anti-HBcore Detectability and Hepatocellular Carcinoma in Patients With HCV-Related Cirrhosis
2008-01-01 Stroffolini, T.; Almasio, P. L.; Persico, M.; Bollani, S.; Benvegnù, L.; Di Costanzo, G.; Pastore, G.; Aghemo, A.; Stornaiuolo, G.; Mangia, A.; Andreone, P.; Stanzione, M.; Mazzella, G.; Saracco, G.; Del Poggio, P.; Bruno, S.; Association of the Study of the Liver Disease, Italian
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?
2008-01-01 Aghemo, A; Rumi, Mg; Colombo, M
Genotype dependent pattern of peginterferon alfa-2b/ribavirin treatment failure in hepatiti sC virus infected patients with cirrhosis : a single center study of 471 naive patients
2008-01-01 Aghemo, A.; Rumi, M.; Monico, S.; Prati, G. M.; Ronchi, G.; Colombo, M.
Increased risk of hepatocellular carcinoma in HCV (+) non responder cirrhotics with high liver cell proliferation
2008-01-01 Donato, M. F.; Arosio, E.; Aghemo, A.; Rumi, M. G.; Ronchi, G.; Colombo, M.
The natural history of portal hypertension in patients with HCV related compensated cirrhosis undergoing interferon ribavirin therapy
2008-01-01 D’Ambrosio, R.; Aghemo, A.; Rumi, M. G.; Primignani, M.; Dell’Era, A.; De Franchis, R.; De Nicola, S.; Lampertico, P.; Colombo, M.
Hepatitis C virus genotypes and patterns of peginterferon alfa-2b/ribavirin treatment failure in patients with cirrhosis : a single center study of 471 naïve patients
2008-01-01 Aghemo, A.; Rumi, M.; Prati, G. M.; Monico, S.; Donato, M. F.; Colombo, M.
Low risk of hepatitis B reactivatioin in patients with chronic hepatitis C and concurrent inactive hepatitis B infection treated with interferon and ribavirin
2008-01-01 Aghemo, A.; Viganò, M.; Iavarone, M.; Rumi, M. G.; Agnelli, F.; Lampertico, P.; Donato, M. F.; Colombo, M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile